Fennec Pharmaceuticals Inc.
|
(Name of Issuer)
|
Common Stock, no par value per share
|
(Title of Class of Securities)
|
31447P100
|
(CUSIP Number)
|
April 30, 2020
|
(Date of Event Which Requires Filing of this Statement)
|
|
☐
|
Rule 13d-1(b)
|
|
☒
|
Rule 13d-1(c)
|
|
☐
|
Rule 13d-1(d)
|
|
1
|
|
NAME OF REPORTING PERSON
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
THE SONIC FUND II, L.P.
|
|
||||||||||||||
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐
|
|||||||||||||||
|
|
|
|
(b) ☐
|
|||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
3
|
|
SEC USE ONLY
|
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|||||||||||||
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
DELAWARE
|
|
||||||||||||||
NUMBER OF
|
|
5
|
|
SOLE VOTING POWER
|
|
||||||||||||||
SHARES
|
|
|
|
|
|
||||||||||||||
BENEFICIALLY
|
|
|
|
|
- 0 -
|
|
|||||||||||||
OWNED BY
|
|
6
|
|
SHARED VOTING POWER
|
|
||||||||||||||
EACH
|
|
|
|
|
|
||||||||||||||
REPORTING
|
|
|
|
|
2,433,230
|
|
|||||||||||||
PERSON WITH
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
- 0 -
|
|
|||||||||||||
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
2,433,230
|
|
|||||||||||||
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
2,433,230
|
|
||||||||||||||
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
☐
|
|||||||||||||||
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
9.4%
|
|
||||||||||||||
|
12
|
|
TYPE OF REPORTING PERSON
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
PN
|
|
|
1
|
|
NAME OF REPORTING PERSON
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
LAWRENCE KAM
|
|
||||||||||||||
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
(a) ☐
|
|||||||||||||||
|
|
|
|
(b) ☐
|
|||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
3
|
|
SEC USE ONLY
|
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|||||||||||||
|
4
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
DELAWARE
|
|
||||||||||||||
NUMBER OF
|
|
5
|
|
SOLE VOTING POWER
|
|
||||||||||||||
SHARES
|
|
|
|
|
|
||||||||||||||
BENEFICIALLY
|
|
|
|
|
62,523
|
|
|||||||||||||
OWNED BY
|
|
6
|
|
SHARED VOTING POWER
|
|
||||||||||||||
EACH
|
|
|
|
|
|
||||||||||||||
REPORTING
|
|
|
|
|
2,433,230
|
|
|||||||||||||
PERSON WITH
|
|
7
|
|
SOLE DISPOSITIVE POWER
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
62,523
|
|
|||||||||||||
|
|
8
|
|
SHARED DISPOSITIVE POWER
|
|
||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
|
|
|
|
2,433,230
|
|
|||||||||||||
|
9
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
2,495,753
|
|
||||||||||||||
|
10
|
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
|
☐
|
|||||||||||||||
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||
|
11
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
9.7%
|
|
||||||||||||||
|
12
|
|
TYPE OF REPORTING PERSON
|
|
|||||||||||||||
|
|
|
|
|
|||||||||||||||
|
|
|
|
IN
|
|
Item 1(a).
|
Name of Issuer:
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices:
|
Item 2(a).
|
Name of Persons Filing:
|
Item 2(b).
|
Address of Principal Business Office or, if none, Residence:
|
Item 2(c).
|
Citizenship:
|
Item 2(d).
|
Title of Class of Securities:
|
Item 2(e).
|
CUSIP Number:
|
Item 3.
|
If this statement is filed pursuant to Section 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
/x/
|
Not Applicable
|
(a)
|
/ /
|
Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o).
|
(b)
|
/ /
|
Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c).
|
(c)
|
/ /
|
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
|
(d)
|
/ /
|
Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
(e)
|
/ /
|
Investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E).*
|
(f)
|
/ /
|
Employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F).
|
(g)
|
/ /
|
Parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G).**
|
(h)
|
/ /
|
Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
|
(i)
|
/ /
|
Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3).
|
(j)
|
/ /
|
Non-U.S. institution in accordance with Section 240.13d-1(b)(1)(ii)(J).
|
(k)
|
/ /
|
Group, in accordance with Section 240.13d-1(b)(1)(ii)(J).
|
Item 4.
|
Ownership.
|
(a) |
Amount beneficially owned:
|
(b) |
Percent of class:
|
(i) |
Sole power to vote or to direct the vote:
|
(ii) |
Shared power to vote or to direct the vote
|
(iii) |
Sole power to dispose or to direct the disposition of
|
(iv) |
Shared power to dispose or to direct the disposition of
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
Item 8.
|
Identification and Classification of Members of the Group.
|
Item 9.
|
Notice of Dissolution of Group.
|
Item 10.
|
Certifications.
|
Dated: February 16, 2021
|
|
|
|
|
THE SONIC FUND II, L.P.
|
||
|
|
||
|
|
|
|
|
By:
|
/s/ Lawrence Kam
|
|
|
|
Name:
|
Lawrence Kam
|
|
|
Title:
|
General Partner
|
|
|
/s/ Lawrence Kam
|
|
|
LAWRENCE KAM
|